Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the third quarter ended September 30, 2014.
Quarter and Recent Highlights
•Increased the number of unique prescribers of OTREXUP™ to approximately 1,000 physicians at the end of the third quarter as compared to approximately 600 physicians at the end of the second quarter, according to Symphony Health Solutions.
Help employers find you! Check out all the jobs and post your resume.
Quarter and Recent Highlights
•Increased the number of unique prescribers of OTREXUP™ to approximately 1,000 physicians at the end of the third quarter as compared to approximately 600 physicians at the end of the second quarter, according to Symphony Health Solutions.
Help employers find you! Check out all the jobs and post your resume.
